thought call
earn strong quarter revenu came slightli
street expect y/i oper growth
encourag sign across ih y/i oper difficulti
see durabl growth trajectori current late-stag pipelin coupl
continu headwind face eh y/i oper revenu guidanc
lower due fx adjust ep increas midpoint larg
driven lower tax rate higher incom partial off-set lower
revenu higher opex believ lower sale guidanc caus
concern remain wari pfe strategi long-term growth particularli
beyond focu smaller-scal deal intern pipelin develop
suspect would less impact larger-scal deal like io could
repres best opportun acceler low single-digit growth
continu see recent restructur announc increment look
decis consum health segment near futur absent right value-
ad deal fail see strong long-term outlook name anticip
share like trade rang near term maintain equal weight rate pt
advanc result phase trial tafamidi expect
european societi cardiolog congress august addit talazoparib
parp inhibitor metastat breast cancer upcom pdufa date decemb
base phase embraca long-term safeti data expect read
tanezumab oa pain recent demonstr strong efficaci result
model updat given perform updat guidanc made
adjust forecast chang non-gaap ep estim move
revenu revenu
quarterli annual ep usd
consensu number thomson reuter receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
return equiti ttm
link barclay live interact chart
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
larg captur upsid key product
prevnar ibranc xtandi absent meaning
busi development/ acquisit see littl
upsid current revenu earn trend
better expect uptak prevnar ibranc
xtandi offset price pressur essenti
coupl pipelin success oncolog
success deploy capit toward could
result upsid forecast
faster eros essenti due price
pressur along lower growth innov could
result weaker top line growth failur deploy
capit pipelin asset could cloud
long-term outlook result share stay
million except per share itemspriorcurr chg amort incom attribut common item net ep ep outstand outstand analysispriorcurr chgchg bp gross changepriorcurr chgchg incom incom million except per share itemspriorcurr chg amort incom attribut common item net ep ep outstand outstand analysispriorcurr chgchg bp gross changepriorcurr chgchg incom incom barclay inc
geoff meacham ph herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli
relat specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
author contribut research report research analyst unless otherwis indic
public date top report reflect local time report produc may differ releas date provid
gmt
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
procedur pleas
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis barclay research depart
oper independ absa research depart absa research produc absa bank limit act corpor
invest bank divis part barclay africa group limit affili invest bank barclay bank plc elig
client may receiv research report research depart may reach differ conclus may contain differ
conflict forecast recommend trade idea
price sourc thomson reuter last avail close price relev trade market unless anoth time sourc
